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a b s t r a c t
In many embryos speciﬁcation toward one cell fate can be diverted to a different cell fate through a
reprogramming process. Understanding how that process works will reveal insights into the develop-
mental regulatory logic that emerged from evolution. In the sea urchin embryo, cells at gastrulation were
found to reprogram and replace missing cell types after surgical dissections of the embryo. Non-
skeletogenic mesoderm (NSM) cells reprogrammed to replace missing skeletogenic mesoderm cells and
animal caps reprogrammed to replace all endomesoderm. In both cases evidence of reprogramming
onset was ﬁrst observed at the early gastrula stage, even if the cells to be replaced were removed earlier
in development. Once started however, the reprogramming occurred with compressed gene expression
dynamics. The NSM did not require early contact with the skeletogenic cells to reprogram, but the
animal cap cells gained the ability to reprogram early in gastrulation only after extended contact with
the vegetal halves prior to that time. If the entire vegetal half was removed at early gastrula, the animal
caps reprogrammed and replaced the vegetal half endomesoderm. If the animal caps carried
morpholinos to either hox11/13b or foxA (endomesoderm speciﬁcation genes), the isolated animal caps
failed to reprogram. Together these data reveal that the emergence of a reprogramming capability occurs
at early gastrulation in the sea urchin embryo and requires activation of early speciﬁcation components
of the target tissues.
& 2014 Elsevier Inc. All rights reserved.
Introduction
It is widely thought that the differentiation potential of a cell
decreases as the cell becomes increasingly speciﬁed (Cherry and
Daley, 2012). However, this view has been challenged by recent
ﬁndings that combinations of deﬁned factors can revert the fate of
a differentiated cell to a pluripotent state in mammals, leading to
induced pluripotent stem cells (iPSCs) (Liu et al., 2008; Park et al.,
2008; Takahashi et al., 2007; Takahashi and Yamanaka, 2006; Yu
et al., 2007). Thus, studying the reprogramming process will yield
insights into how the gene regulatory system buffers perturba-
tions and faithfully carries out the developmental program, and in
addition provide useful information for regenerative medicine and
disease modeling (Cherry and Daley, 2012).
The sea urchin embryo provides an excellent platform for
studying reprogramming. It exhibits high developmental plasticity
in that an isolated blastomere from the 4-cell stage embryo
develops into a complete pluteus larva, a phenomenon that led
to the original concept of “regulative” development (reviewed by
Hörstadius, 1973). Later in development, when cells speciﬁed
toward one fate were surgically removed, cells of other fates
reprogrammed to replace the missing cells, a process referred to
at the time as “transfating” (Ettensohn and McClay, 1988; McClay
and Logan, 1996; Ettensohn et al., 2007). Those cell fate switches
during sea urchin embryonic development altered the gene
regulatory networks (GRNs) governing speciﬁcation (Davidson,
2006; Davidson et al., 2002), and resulted in a dynamic and
qualitative transition to a different GRN state. The remarkable
advance in knowledge of the sea urchin GRN provides an excellent
platform for a systems analysis of this reprogramming mechanism.
In the sea urchin, the skeletogenic lineage arises from four large
micromeres formed at the vegetal pole of the embryo as a result of
two consecutive asymmetric cleavages at the 16-cell and 32-cell
stages. At the mesenchyme blastula stage, descendants of large
micromeres undergo an epithelial-mesenchymal transition (EMT)
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and ingress into the blastocoel to form the primary mesenchyme
cells (PMCs). The PMCs migrate to speciﬁc locations in the blasto-
coel, fuse via syncitial cables, and secrete the calcium carbonate
skeleton of the larva. When skeletogenic cells were removed,
either at the 16-cell stage as micromeres or at the mesenchyme
blastula stage as PMCs, non-skeletogenic mesoderm cells (NSM)
reprogrammed to assume a skeletogenic fate (Ettensohn and McClay,
1988; Sweet et al., 1999). If the PMCs and the archenteron tip (all
mesoderm) were removed, the remaining presumptive endoderm
reprogrammed to assume skeletal and other mesodermal fates
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Fig. 1. Skeletogenic reprogramming in micromere (-) embryos occurs after a long delay. (A) (Left panel) Illustration of the experiment. At the 16-cell stage micromeres were
removed (micromere(-), blue), or at the mesenchyme blastula stage PMCs were removed (PMC(-), red). (Right panel) Explanation of the qPCR plots. (B–H) Analysis of (B)
pmar1, (C) alx1, (D) tbr, (E) alx1, late, (F) vegfr, (G) msp130, early, and (H) msp130 late. Horizontal axes give hours post fertilization (hpf) until morphogenesis: MB,
mesenchyme blastula; EG, early gastrula; MG, mid-gastrula; LG, late gastrula; PR, prism; PL, pluteus. In each plot, the normalization standard sample is indicated by a * sign,
and has the relative expression value of 1.
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(McClay and Logan, 1996; Sharma and Ettensohn, 2011). From these
studies it was clear that the remaining mesoderm or even endoderm
had the capacity to reprogram and replace missing skeletogenic cells.
McClay and Logan (1996) showed that if parts of the gut were
removed, it too was replaced through reprogramming. In the literature
this cell fate change is sometimes referred to classically as “morphal-
lactic regeneration” (Reddien and Sanchez Alvarado, 2004) where one
cell type changes to a different cell type. Here we use the term
“reprogram”, for the process to indicate that cells normally headed
toward one fate demonstrate the capacity to move to a different fate.
We distinguish this reprogramming from “regulative” development
because, as shown in the experiments below, the regulative changes
classically reported in the literature and in textbooks are largely
restricted to very early cleavage, before cell speciﬁcation has pro-
gressed very far. Here we show that the regulative capacity ends long
before a reprogramming ability can be demonstrated.
Cells of the animal half of the embryo normally are fated to become
ectoderm and neural ectoderm. Studies by Hörstadius demonstrated
that these animal cap cells could give rise to vegetal tissues (including
endoderm) if isolated and supplied with micromeres at the 16-cell
stage, but that inductive capacity could no longer be demonstrated if
micromeres were added to animal caps isolated after the 32-cell stage.
The animal cap cells lost responsiveness to micromere induction since
neither younger nor older micromeres induced regulative change if
added to animal caps from 32-cell stage embryos or older (Hörstadius,
1939, 1973). Thus, a capacity for large inductive and/or regulative
change could be demonstrated experimentally between 2 and 32 cell
stages, but after that any changes were much more modest, if present
at all. These data were in stark contrast to the transfating experiments
that demonstrated a later plasticity in reprogramming.
Here we conﬁrm that those regulative capacities are lost early
in cleavage, and after that, isolated embryo fragments appear to be
largely refractory to an alteration in fate until the beginning of
gastrulation, at which time the remaining cells of the embryo
demonstrate a remarkable ability to reprogram. We returned to
the reprogramming question in an attempt to begin to understand
the molecular events behind the process in two cases of repro-
gramming. Work on Primary Mesenchyme Cell-depleted embryos
(henceforth referred to as PMC(-) embryos, see Fig. 1A) earlier had
revealed that about 2–3 h after removal of PMCs, non-skeletogenic
mesenchyme (NSM) cells began to express PMC markers indicat-
ing that reprogramming had begun (Sharma and Ettensohn, 2011).
In the present study, we began by asking if removal of the PMC
predecessors, the micromeres, was followed by a similar 2–3 h
delay before replacement was launched. To our surprise there was
a much longer delay before there was any evidence of micromere/
PMC replacement. Once the reprogramming began, however, the
skeletogenic temporal gene expression program was substantially
compressed, occurring in about 1/2 of the time normally taken by
micromeres during their speciﬁcation sequence. The NSMs that
reprogrammed transiently co-expressed both skeletal and NSM
marker genes as the reprogramming progressed.
We then asked whether other parts of the embryo reprogrammed
with a delayed response. Hörstadius' result showing that animal caps
quickly lost their inductive response capacity (by the 32-cell stage)
was conﬁrmed, and we then found that animal cap descendants
obtained an ability to reprogram but only when they reached the
beginning of gastrulation, at roughly the same time reprogramming
to replace PMCs was initiated. Unlike reprogramming of PMCs,
however, the animal cap's ability to reprogram required extended
contact with the vegetal half embryo until gastrulation. Thus the
embryo has the ability to reprogram cells of one germ layer to
another and this capacity apparently includes much of the embryo.
The reprogramming ability does not appear until early gastrulation,
and the reprogramming requires expression of transcription factors
used in early speciﬁcation of the target tissues.
Materials and methods
Animals
Adult Lytechinus variegatus were obtained from Duke Marine
Laboratory (Beaufort, NC, USA) and Reeftopia Inc. (Key West, FL, USA).
The embryos were cultured at 23 1C.
Quantitative Polymerase Chain Reaction (qPCR) and Whole Mount
in situ Hybridization (WMISH) analyses
Total RNA was extracted from 15–25 live L. variegatus embryos
using the RNeasy Plus Micro Kit (QIAGEN) and eluted in nuclease-
free water. For the 2.5 hpf (hours post fertilization) time point,
micromere(-) embryos were lysed and homogenized in Buffer RLT
Plus (QIAGEN) with 2-Mercaptoethanol added within 5 min of
micromere removal. cDNA synthesis was performed using the
iScript cDNA Synthesis Kit (Bio-Rad). Quantitative PCR reactions
were performed using an Eppendorf Mastercycler ep realplex
system and Power SYBR Green PCR Master Mix (ABI). QPCR results
were analyzed following the 2ΔΔCT method described by Livak
and Schmittgen (2001), using ubiquitin as the normalization gene
(Rho and McClay, 2011). Chromogenic and ﬂuorescent WMISH
using published anti-sense RNA probes (Croce and McClay, 2010)
followed procedures described earlier (Rho and McClay, 2011).
Microsurgery and microinjections
The micromere and PMC removal procedure has been described
previously (Sweet et al., 2004). The micromeres were removed at
16-cell to 32-cell stage, approximately 2.5–3 hpf, resulting in micro-
mere(-) embryos. PMCs were removed at mid to late mesenchyme
blastula stage, resulting in PMC(-) embryos. Fluorescent dye FITC
(green) or Rhodamine dextran (red) was injected into one-cell stage
embryos shortly after fertilization. Animal half embryos were isolated
from chimeras produced earlier by combining green ﬂuorescent
animal halves and red ﬂuorescent vegetal halves at the 16–32-cell
stage. Vegetal half separations were performed under ﬂuorescent
light to provide the cleanest possible separation of animal and
vegetal halves. As controls for these experiments recombined animal
and vegetal halves, if allowed to develop, produced normal pluteus
larvae with green ectoderm and red mesoderm and endoderm.
Also, most micromere(-) and PMC(-) embryos eventually produced
normally patterned larvae if allowed to develop. Morpholinos used
were previously published, including extensive controls to show that
knockdowns did not include off-target consequences (Oliveri, et al.,
2006; McIntyre et al., 2013). Pmar1mRNAwas prepared as described
before (Wu andMcClay, 2007), and was injected at a concentration of
200 ng/µL.
Results
Skeletogenic reprogramming of non-skeletogenic mesoderm occurs
with a delay in micromere-depleted embryos
In a L. variegatus embryo grown at 23 1C, the micromeres
appear at 2.5 hpf (hours post fertilization), become primary
mesenchyme cells (PMCs) at 9.5 hpf, and begin synthesizing the
larval skeleton at about 14 hpf, shortly after archenteron invagina-
tion begins. Earlier it was shown that if the PMCs were surgically
removed, non-skeletogenic mesoderm (NSM) cells, a subpopula-
tion derived from macromeres of the 16-cell stage embryo,
quantitatively replaced the missing PMCs by reprogramming to
a skeletogenic fate (Ettensohn and McClay, 1988). Evidence of
replacement was ﬁrst seen about 3 h after PMCs were removed
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from mesenchyme blastula stage embryos. At that time transcrip-
tion factors speciﬁc for the skeletogenic fate were expressed by
NSM indicating that reprogramming had been initiated (Ettensohn
et al., 2007; Sharma and Ettensohn, 2011). These data suggested
the possibility that reprogramming of the NSM was triggered
quickly after cell loss. If that were true, we predicted that
reprogramming also would initiate quickly if the PMC precursors,
the micromeres, were removed at 2.5 hpf (micromere(-) embryos).
Unexpectedly, the micromere(-) embryos did not express PMC
lineage-speciﬁc markers until early gastrulation, at about 12.5 hpf,
or at the same time the PMC(-) embryos had expressed the
skeletogenic markers. Alx1 is a transcription factor expressed
exclusively by the skeletogenic lineage and normally is expressed,
and required, early in the speciﬁcation of that lineage (Ettensohn
et al., 2003, 2007) (Fig. 1). The experiments revealed that it did not
matter whether skeletogenic precursors were removed at 2.5 hpf
or at 10 hpf, the reprogramming to replace them, as deﬁned by
appearance of alx1 expression, did not appear until about 12.5–
13 hpf. To learn more about the extended delay in onset of
reprogramming of NSMs we began by quantitatively assessing
the expression of markers, starting with the most upstream
skeletogenic factor, pmar1 (Oliveri et al., 2002). In control
embryos, expression of pmar1 begins shortly after micromere
formation at 2.5 hpf in L. variegatus, and is followed by expression
of alx1 (Ettensohn et al., 2003) and tbr (Croce and McClay, 2010)
at 4.5 hpf, vegfr (Duloquin et al., 2007) at about 8.5 hpf andmsp130
(Leaf et al., 1987) at about 8–9 hpf. Each of these genes is
expressed exclusively in the skeletogenic lineage downstream of
pmar1 and here they are used as markers of the skeletogenic cell
speciﬁcation temporal sequence. At the 16-cell stage micromeres
were removed, or PMCs were removed at the mesenchyme
blastula stage, and in both cases, embryos were immediately
processed for qPCR analysis, or grown in seawater for a period of
time and then processed for qPCR analysis. pmar1 mRNA was
Fig. 2. (A) Experimental procedure for obtaining micromere(-) embryos overexpressing pmar1 in macromeres. (B) A micromere(-) embryo overexpressing pmar1 in its
macromeres, with the animal cap cells labeled by rhodamine dextran (red) and progeny of pmar1-injected macromeres labeled by FITC (green). (C) alx1 in situ hybridization
for the same embryo in (B) indicating the activation of alx1 in half of the embryo. (D–G) A sibling embryo of (B) developed to 26 hpf. (D) The gastrulated embryo showed
increased number of ingressed cells in the blastocoel. (E) The ingressed cells derived almost entirely from pmar1-injected macromere labeled with FITC (green) and started to
aggregate on the sides of the archenteron. (F) Animal cap cells labeled with rhodamine dextran (red) contributed to the archenteron. (G) in situ hybridization of tbr for the
same embryo in (D–F) showing that the FITC-labeled cells (green) were tbr expressing skeletogenic cells.
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expressed in embryos lacking micromeres at the time of micro-
mere removal (embryos were processed for RNA no later than
5 min after micromeres were removed), albeit at a much reduced
level compared to the sibling controls, suggesting that pmar1
expression is not initially restricted to micromeres (Fig. 1B).
Initially we thought this might represent an early activation of a
reprogramming capacity. However, alx1 and tbr expression did not
follow in this low level of pmar1 expression in the micromere(-)
embryos as it normally does in micromeres (Oliveri et al., 2002).
There was no evidence of any of the downstream micromere or
PMC markers in micromere(-) embryos when the sibling controls
reached mesenchyme blastula (MB) stage (about 9.5 hpf). Alx1 and
tbr markers ﬁnally were expressed at gastrula stage in micromere
(-) embryos, indicating that the NSM cells apparently did not
initiate reprogramming to a PMC fate until that time (Figs. 1C and
D). We hypothesized that in embryos lacking presumptive skele-
togenic lineage, that the sequence of reprogramming would follow
a similar trajectory as it had earlier in micromeres. We observed
that Pmar1 was not expressed in PMC(-) embryos by the NSM, as
also reported previously in PMC(-) experiments (Ettensohn, et al.,
2007). We examined the expression of alx1, vegfr, and msp130 in
both micromere(-) and PMC(-) embryos. Alx1 was expressed at
levels equal to, or higher than the controls in both micromere(-)
and PMC(-) embryos at early gastrula (EG) stage (Fig. 1E). Expres-
sion of vegfr, and msp130 also followed indicating that reprogram-
ming at least roughly followed the skeletogenic speciﬁcation
sequence in both micromere(-) and PMC(-) embryos (Figs. 1F,G).
Micromere(-) embryos left in culture produced normally pat-
terned skeletons indicating that reprogramming reached
completion.
We wondered if the reduced level of pmar1 in micromere(-)
embryos, presumably expressed in macromeres and their progeny,
was simply insufﬁcient to activate skeletogenesis in these cells. To
test this, we examined expression of alx1 in micromere(-) embryos
after misexpressing pmar1 in the macromeres (Fig. 2A and B).
in situ analysis indicated that alx1 indeed was expressed in these
embryos at 8.5 hpf (Fig. 2C), much earlier than observed in
uninjected micromere(-) embryos (Figs. 1C and E). These embryos
later produced excessive numbers of ingressed cells that, by
in situ, stained positively for tbr (Figs. 2D–G), a marker of the
skeletogenic fate. These data show that the remaining embryo is
able to reprogram early but only if artiﬁcially activated by over-
expression of key transcription factors. In the absence of an
artiﬁcial stimulus micromere(-) embryos reprogram cells to the
skeletogenic fate but with an initiation delay until the early
gastrula stage. The low level of pmar1 observed in macromeres
apparently occurs normally but is quantitatively insufﬁcient to
activate skeletogenesis if micromeres are removed early. The
reprogramming at early gastrula bypasses a need for Pmar1. Thus,
both micromere(-) and PMC(-) embryos activated skeletogenic
reprogramming at early gastrulation. The NSM cells that replaced
the PMCs showed no evidence of reprogramming prior to early
gastrula, no matter when the micromere/PMCs were removed.
Once initiated, reprogramming of non-skeletogenic mesoderm to
PMCs occurs with compressed timing.
A recent study reported that the sequence of skeletogenic gene
activation during NSM reprogramming in PMC(-) embryos was
similar to that expected of normal development (Sharma and
Ettensohn, 2011), although it bypassed expression of pmar1
(Ettensohn et al., 2007). Activation of alx1 normally is followed
by vegfr expression after about a 4–5 h interval. Our qPCR analyses
of micromere(-) embryos tended to agree with that earlier ﬁnding
except it indicated that vegfr was activated with less delay relative
to alx1 expression onset than is observed in the normal timing of
expression of these markers. This suggested the possibility that
reprogramming to a skeletogenic fate, once started, might occur
with dynamics different from normal embryos. To more precisely
examine the dynamic expression pattern of the factors used as
temporal markers, we performed in situ analyses on micromere(-)
embryos at frequent intervals from 6.5 hpf to 20.5 hpf. Consistent
with our qPCR data, alx1, vegfr and msp130 were expressed in
micromere(-) embryos by 12.5 hpf (Fig. 3) indicating only a short
delay between alx1 activation as a sign of reprogramming, and
expression of downstream genes (in fact vegfr was expressed prior
to alx1 in some micromere (-) embryos). The interval was reduced
to as short as 1–2 h (for msp130) relative to the roughly 4 h
interval seen during normal micromere speciﬁcation, and vegfr
expression was even earlier. The timing of gene expression
obtained from this experiment suggests that once NSM repro-
gramming is initiated the reprogramming sequence is signiﬁcantly
compressed temporally relative to the endogenous timing of the
micromere speciﬁcation sequence.
In PMC(-) embryos, NSMs undergoing reprogramming co-
express alx1 and an NSM cell marker scl (Sharma and Ettensohn,
2011). We wondered if this hybrid regulatory state occurred in
micromere(-) embryos during the reprogramming phase as well.
Cells in the vegetal plate of micromere(-) embryos indeed
expressed scl and alx1 at 12.5 hpf (Fig. 3), and the expression of
both became strong in cells covering the cap of the archenteron
during gastrulation (Fig. 3, Fig. 4A). Fluorescent two-color in situ
hybridization showed that expression of alx1 and scl was by the
same cells (Fig. 4A). Unlike PMC(-) embryos where vegfr was only
expressed when the alx1/scl co-expressing cells acquired
mesenchymal character and left the tip of the archenteron
(Sharma and Ettensohn, 2011), in micromere(-) embryos vegfr
and sclwere also co-expressed with both genes in the same spatial
domain (Fig. 4B) at 14.5 hpf and prior to the departure of the
reprogrammed PMCs from the archenteron. Control embryos at a
similar developmental stage showed completely distinct patterns
of expression (Fig. 4C,D). These observations indicate an inter-
mediate state when both NSM and skeletogenic genes are
expressed. Thus, the data suggest that the transition is not a
simple ﬂipping of a switch, but that to reprogram there is an
extended inﬂuence on the transiting cell so it continues its
reprogramming trajectory. In this case the NSM is the cell type
that reprograms in the absence of PMCs or micromeres. The
inﬂuence that triggers the reprogramming is unknown but could
be a lack of reception of a signal normally produced by PMCs.
Reprogramming of animal cap cells occurs after extended
speciﬁcation by vegetal tissue
We next looked at animal cap cells to ask whether the
micromere-PMC-NSM cells reprogramming transition was unique
to that group of cells, or whether other cells of the embryo also
could reprogram with a similar delayed onset.
We ﬁrst asked if and when isolated animal caps acquired an
ability to reprogram and replace the endomesoderm. From the
classical studies of Hörstadius and others animal caps isolated at
the 16-cell or 32-cell stage form only dauer blastulae and do not
exhibit a reprogramming capacity, though at the 16–32-cell stage
animal caps responded to inductions (Hörstadius, 1939, 1973;
Amemiya, 1996). However, in further study, Hörstadius also
observed that after the 32-cell stage the animal cap cells also lost
the ability to be induced by micromeres, even if the micromeres
were younger 16-cell, induction competent cells (Hörstadius,
1939). We wondered whether the animal cap cells were perma-
nently locked out of an ability to reprogram or whether they might
be like the micromere-NSM replacement cells and reprogram
if isolated later in development. We began by repeating the
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Hörstadius experiment and assessed both the duration of time
animal caps responded to micromere induction, and the response
of animal caps if isolated at later and later stages. Gut formation
was used as the primary phenotypic indicator of successful
induction or reprogramming change. We also examined the
expression pattern of gut speciﬁc marker genes in recombinant
embryos. To assure that we examined only animal cap tissue,
animal caps (all 8 mesomeres) were surgically isolated from 32-
cell stage embryos and were cultured for 0 h, 1.5 h, 3 h and 5.5 h
before being recombined on the vegetal side with a 16-cell stage
micromere quartet labeled with a ﬂuorescent dye (Fig. 5A). After
the animal cap ring received micromeres at the 32-cell stage, the
skeletogenic marker alx1 was expressed later by all the ingressed
PMCs (Fig. 5B,D) and the early endomesoderm marker foxA was
produced by the responding animal caps and localized to a small
region of the blastula (Fig. 5C, E). When observed at 25 hpf, a
signiﬁcant number of the 16-cell micromere to 16–32-cell animal
cap recombinants (8/14) gastrulated and developed to the pluteus
stage (Fig. 5F,G). Thus, consistent with Hörstadius' observations
32-cell stage animal caps were capable of being induced by
micromeres to give rise to a gut and correctly pattern the added
PMCs. However, after that the animal caps became refractory to an
induction response. if animal caps were isolated at 32-cell stage,
then incubated for 1.5 h or more before receiving 16-cell
Fig. 3. Reprogramming occurs with compressed temporal dynamics. WMISH analysis of alx1,msp130, vegfr, and scl expression in control embryos (Con) and in micromere(-)
(m-) embryos over time. Numbers at top are hours post fertilization (hpf). Red vertical bars mark the approximate time each row demonstrated expression of the gene in
question. First expression of alx1 in controls actually occurs at 4.5 hpf (see Fig. 1C). As indicated by the red bars, in controls there is a 4 h interval between expression of alx1
and msp130 and vegfr. In the reprogramming NSM cells alx1 is seen at 12.5 hpf while msp130 is seen within an hour of that, and vegfr actually precedes expression of alx1
suggesting temporal compression relative to the sequence in normal development.
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micromeres, the animal caps failed to respond to the micromere
induction (Fig. 5H–K). These embryos produced an incorrectly
patterned calcium carbonate skeleton derived entirely from trans-
planted micromeres. Animal caps that never received micromeres
became dauer blastulae (Fig. 5L) Animal caps isolated between
the 32-cell stage and mesenchyme blastula also became dauer
blastulae. These observations showed that animal cap cells initially
respond to micromere induction if at the 16–32-cell stage, but lose
this inductive competence shortly thereafter during cleavage, and
by themselves, demonstrated no capacity for reprogramming up to
the mesenchyme blastula stage (about 9 hpf).
There was a dramatic change as we isolated animal caps at later
and later stages. Animal caps isolated from the beginning of
gastrulation and beyond reprogrammed and replaced vegetal
tissues remarkably well. To clearly distinguish cells with animal
or vegetal half origin, we established an assay in which each
embryo was a chimera of a normal animal half labeled with a
ﬂuorescent dye, and a normal vegetal half labeled with a different
ﬂuorescent dye, obtained and recombined at the 16 to 32-cell
stage (Fig. 6A). At each isolation time point, best attempts were
made to remove all cells of vegetal origin (Figs. 6B–F). Most
animal-vegetal separations were complete, however at later stages
a few PMCs tended to adhere tightly to the basal lamina, so we
were unable to remove all PMCs from some of those older
embryos. Nevertheless, results of this set of experiments were
quite clear. After not responding if isolated between the 60-cell
stage (3 hpf) and 12 hpf (Fig. 6B,C), isolated animal caps began to
demonstrate reprogramming abilities and replaced missing germ
layers (4/6, and 3/5 in two initial trials when animal caps were
isolated at early gastrula, Fig. 6D). Many of these animal caps
contained correctly patterned PMCs and coelomic pouches in
addition to a gut, all from animal cap cells (Fig. 6D, upper panels
imaged at 42 hpf), and in further experiments where embryos
were cultured longer the animal caps became pluteus larvae (see
Fig. 7). Animal caps isolated at the mid-gastrula stage (Fig. 6E) or
later still reprogrammed to replace missing parts as well, and later
expressed the endoderm marker gene endo16 (Romano and Wray,
2003) (Fig. 6E lower panels). Thus, the presumptive ectoderm is
able to reprogram but only after reaching a certain speciﬁcation
state and only after being in contact with the vegetal halves until
gastrulation (because animal caps isolated from embryos between
3–10 hpf developed only as dauer blastulae). Perhaps not coin-
cidentally, the timing of the reprogramming onset by ectoderm
(12–13 hpf) coincided with the time NSMs ﬁrst demonstrated their
capacity to switch to PMCs in both micromere(-) and PMC(-)
embryos. Thus the sea urchin embryo has a remarkable ability to
completely re-pattern the limits of germ layers using the remain-
ing cell population and to adjust relative proportions, and experi-
ments suggest this ability is ﬁrst initiated at early gastrula stage.
Reprogramming requires activation of endomesoderm speciﬁcation
genes as animal cap cells switch to new cell fates
For animal cap cells to switch cell fates we predicted that it
would be necessary to use endomesoderm speciﬁcation genes to
accomplish this transition. We designed an assay to test this
prediction using two of early speciﬁcation genes necessary for
endomesoderm. Hox11/13b is an early endomesoderm transcrip-
tion factor that is activated prior to hatched blastula and is near
the top of the endoderm GRN (Peter and Davidson, 2010). FoxA
is also an endoderm speciﬁcation transcription factor that is
activated early in endomesoderm speciﬁcation, is necessary for
endoderm speciﬁcation, and is downstream of Hox11/13b (Oliveri
et al., 2006; Peter and Davidson, 2011). Chimeric embryos were
produced as before at the 32-cell stage with each half labeled
with red or green ﬂuorescent markers. Morpholinos to either
Hox11/13b or FoxA were co-injected with one of the ﬂuorescent
markers so that the morpholino was present either in the animal
caps or the vegetal halves of the experimental chimeras. Then, at
various times the animal caps were separated from the vegetal
halves and cultured to 48 hpf, or control chimeras were never
separated.
Control chimeras without morpholinos developed to the
pluteus stage with the red-green boundary at predicted locations
Fig. 4. During reprogramming PMC and NSM markers are co-expressed. (A) Expression of scl and alx1 in reprogramming NSMs at 16.5 hpf. (B) Expression of alx1 and vegfr in
reprogramming NSMs at 14.5 hpf. (C and D) scl and vegfr expressed in separate lineages in control embryos at 14.5 hpf (C), and 16.5 hpf (D).
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based on earlier lineage analyses (n¼8/9; Fig. 7A). If the animal
caps were separated from the vegetal halves of control embryos
at early gastrula, 13/13 reprogrammed to produce endoderm
and mesoderm (9/13 became plutei; 4/13 were late gastrulae at
48 hpf; Fig. 7D,G). If the morpholino for Hox11/13b or FoxA was
present only in the animal cap the intact chimeras developed to
Fig. 5. Animal cap cells lose an ability to regulate during early cleavage stages. (A) Schematic of the experiment. Unlabeled animal cap cells isolated from 32-cell stage embryos
were cultured for 0, 1.5, 3, or 5.5 h before receiving freshly isolated micromere quartets from ﬂuorescently labeled 16-cell stage donor embryos. Numerals at the top of each arrow
indicate the times elapsed before isolated animal halves received donor micromere quartets. (B–E) in situ images of embryos developed from an animal half receiving micromere
quartet immediately after isolation, ﬁxed at 13 hpf. (B,D) in situ hybridization of alx1 in the chimera embryo. (C,E) in situ hybridization of foxA in the chimera embryo. (F–K)
Embryos developed from an animal half receiving FITC labeled (green) micromere quartet. (F) micromeres received at 32-cell stage, imaged at 25 hpf and (G) 60.5 hpf;
(H) micromeres received after 1.5 h of isolated culture, imaged at 25 hpf; (I) micromeres received after 3 h of isolated culture, at 25 hpf and (J) 49.5 hpf; (K) micromeres received
after 5.5 h and imaged at 25 hpf. (L) A dauer blastula developed from an isolated animal half that never received micromeres. SV side view, VV ventral view.
Fig. 6. Animal caps reprogram. (A) Embryos were produced with animal caps and vegetal halves labeled with different ﬂuorescent dyes and recombined at the 16 to 32-cell
stage. (B–F) After 6, 9, 12, 13.5 and 15 hpf the red and green halves were separated. (B,C) Halves separated at 6 and 9 hpf did not develop beyond dauer blastulae. (D–F)
Animal halves isolated at 12, 13.5 or 15 hpf, contributed to vegetal germ layers (7/11 at 12 hpf; 3/4 at 13.5 hpf; 4/9 at 15 hpf in this experiment). In E, lower right panel, in situ
for endo16 of the same embryo seen to its left.
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pluteus larvae also, presumably because neither Hox11/13b nor
FoxA are necessary for speciﬁcation of animal cap-derived tissues
(Hox11/13b n¼18/18; Fig. 7B; FoxA n¼4/6; Fig. 7C). The only
exception to this was that the FoxA animal cap knockdowns did
not develop a mouth, but since FoxA is known to be necessary for
stomodeum development this was not a surprise (Fig. 7C) (Oliveri
et al., 2006). On the other hand if the morpholinos were present
only in the vegetal halves of chimeras left intact, endomesoderm
development was severely compromised (Hox11/13b knockdowns,
n¼7/16 had partial guts, 9/16 had no recognizable guts; FoxA
knockdowns, n¼1/7 had a partial gut, 6/7 had no recognizable
guts; data not shown).
Fig. 7. Endoderm GRN necessary for reprogramming. Red/green half embryos were recombined at the 32-cell stage and imaged at 48 hpf. In each case the embryos were imaged in
both the red and green channels andmerged. (A). Control red animal cap embryo recombined with a green vegetal half embryo. (B). Green Hox11/13b knockdown in the animal cap
recombined with a control red vegetal half embryo. (C). Green FoxA knockdown in the animal cap recombined with control red vegetal half. Note: there is no mouth. (D). Control
red animal cap after removal of green control vegetal half at EG. (E). Green Hox11/13b knockdown animal cap after removal of control red vegetal half at EG. (F). Green FoxA
knockdown animal cap after removal of control red vegetal half at EG. (G). Control green animal cap after removal of control red vegetal half at EG. (H). Control red animal cap after
removal of green Hox11/13b knockdown vegetal half at EG. (I). Control red animal cap after removal of green FoxA knockdown vegetal half at EG. (J). Red animal cap isolated at
32-cell stage and imaged at 48 hpf. (K). Red animal cap recombined with green control vegetal half at 32-cell stage, isolated at HB, and imaged at 48 hpf. (L). Green animal cap
recombined with red vegetal half at 32-cell stage and half the red vegetal half removed at HB. HB, hatched blastula (7.5 hpf); EG, early gastrula (13–14 hpf).
X. Cheng et al. / Developmental Biology 391 (2014) 147–157 155
With the above as controls we now examined animal caps
isolated at early gastrula in which the morpholinos were either
carried in the animal caps, or in the vegetal halves. If the animal
caps carried Hox11/13b morpholino or FoxA morpholino they lost
much of their capacity to reprogram (Hox11/13b, n¼2/13 had any
recognizable gut or mesenchyme cells; Fig. 7E; FoxA, n¼0/7 had
gut or mesenchyme; Fig. 7F). Thus, although the animal cap cells of
intact chimeras participated normally in ectoderm development
and patterning while carrying the Hox11/13b or FoxA morpholinos
in the animal caps, those same cells were unable to reprogram to
replace endomesoderm. This supports the hypothesis that, like the
transfating of the NSM cells to replace PMCs, the animal caps must
express endomesoderm speciﬁcation components to accomplish
reprogramming.
If the vegetal halves carried the morpholinos there was a distinct
outcome. Remember, for the animal caps to reprogram they had to be
in contact with the vegetal halves until mesenchyme blastula stage.
Isolation of animal caps prior to that resulted in dauer blastula
formation (Figs. 7J,K). If, in the chimera experiment, the vegetal halves
carried the Hox11/13 morpholino, the isolated animal caps (again,
isolated at early gastrula) were severely compromised in their ability
to reprogram (4/14 had any guts or skeleton from the animal cap
halves, Fig. 7H). If the vegetal halves carried the FoxA morpholino, the
isolated animal caps were better able to reprogram (n¼6/7 had
endoderm and/or mesoderm, Fig. 7I), suggesting that a hypothetical
vegetal signal required for animal cap reprogramming capability
does not require FoxA for its production. Since the vegetal signal is
only hypothetical based on the observations of these experiments,
the actual vegetal input to the animal cap that enables reprogramming
has yet to be discovered, but it likely is expressed downstream of
Hox11/13b.
Finally, we asked what would happen if we separated the animal
caps from the vegetal halves but included some of the vegetal tissue
on purpose. The embryos adapted quite well, and developed to the
pluteus stage (n¼5/5; Fig. 7L). In each case they used the remaining
vegetal tissue for endomesoderm tissues, but incorporated animal
cap tissue to replace some of the missing vegetal tissue. Notice in
Figs. 7L a gut formed from the remaining endomesoderm tissue (red
in this chimera), but part of the gut was ﬁlled in with animal cap
tissue (green). Given the outcome of the timing seen in reprogram-
ming to replace the PMC and gut, we assume that when parts of the
animal or vegetal tissue were removed earlier than 12 hpf, that
replacement did not begin until early gastrula.
Discussion
Reprogramming, regulative development and regeneration
Contrary to the common notion that cell fate switching
potential declines monotonically during development, evidence
here suggests that speciﬁed cells in the sea urchin embryo initiate
a reprogramming capacity after, and not before they reach a
relatively advanced state of speciﬁcation toward their normal fate.
This delayed emergence of reprogramming in response to tissue
removal may be a more general feature of development in many
organisms rather than speciﬁc to sea urchins. Other species in the
animal kingdom also exhibit remarkable ability to reprogram cell
fates in later stages of development. Asexual budding by free-
living larvae has been reported in several echinoderm classes
(Eaves and Palmer, 2003; Vaughn and Strathmann, 2008). In lobate
ctenophores, although their embryonic development is generally
mosaic, the adults exhibit high regenerative ability. Speciﬁc
populations of cells replace missing body structures but the
replacement was demonstrated to happen only after the animal
developed into the adult stage, a phenomenon referred to as
“post-regeneration” (Henry and Martindale, 2000).
Our results further suggest a distinction between the so-called
regulative capacity of sea urchins and the reprogramming activity
that emerges later in development. The classical concept of
regulative development was deﬁned experimentally as the ability
of early blastomeres to produce something other than what they
would normally make, a phenomenon also seen in reprogram-
ming. The difference is that all regulative development demon-
strations occur before the blastomeres begin or progress deeply
into their speciﬁcation program. Here, by contrast, after a long
period during which the cells demonstrated essentially no plasti-
city, isolated tissues gained the ability to reprogram. The repro-
gramming appears different from epimorphosis regeneration in
that during epimorphosis cells typically de-differentiate from the
fully differentiated state, and then are reprogrammed to form the
same or a different cell type. In the case of the sea urchin the
responding cells transit through intermediate states where both
previous and reprogrammed markers are present, and the transit
is compressed temporally relative to the control speciﬁcation
sequence for a tissue. The reprogramming is also different from
stem cell-mediated replacement of cells because the cells that
respond are not a set-aside population of pleuripotent cells. The
cells that reprogram presumably are inﬂuenced by changes in a
signaling environment that causes a change in their fate. Sea
urchins thus demonstrate a remarkable ability to reprogram at
many stages of their life history. The capacity demonstrated here,
as with other stages, aligns most closely with morphallactic
regeneration in which existing tissues are repatterned or repro-
grammed. Here, we show that reprogramming occurs beginning at
gastrulation. It may well be that the capacity for regeneration in
adults (Ebert, 1967), is initiated at gastrulation as seen here.
A mechanistic view of reprogramming
Transcription factors necessary for specifying a lineage during
normal development were also necessary for reprogramming to that
lineage. This suggests, perhaps not surprisingly, that the regulatory
logic underlying normal development, (Davidson, 2006; Davidson et
al., 2002), is used also to achieve cell fate reprogramming. It was
shown earlier that the cell fate transition does not necessarily return
to the beginning of a speciﬁcation sequence (Ettensohn et al., 2007),
but the transition includes at least part of the original speciﬁcation
sequence. Thus reprogramming may be understood in terms of the
regulatory logic organizing normal development. The key is to ﬁgure
out how the initial switch is made. In Lytechinus growing at 23 1C the
step time between successive regulatory transactions is approxi-
mately twice as fast as those observed in Strongylocentrotus purpur-
atus which was previously calculated to be about 3 h (Peter et al.,
2012). In the reprogramming sequence seen here, the interval
between expression of the ﬁrst transcription factor (alx1) and
differentiation genes (msp130 and vegfr), which had been 4–5 h
during normal speciﬁcation, was less than an hour in the reprogram-
ming. These data suggest that there was time for no more than one
or perhaps two steps in that particular reprogramming sequence.
Network theory and experiment suggest that different cell fates
correspond to distinct attractors of GRN dynamics (to use the
language of that ﬁeld) (Huang et al., 2005; Kauffman, 1969). By that
concept micromere(-), PMC(-) and normal embryos move along
different trajectories in gene expression state space, and converge,
experimentally, at the skeletal fate attractor. If that is true, the
appearance of reprogramming capacity at a rather precise time in
the developmental sequence provides an attractive target period for
application of recently proposed mechanistic mathematical models
of the GRN that attempt to explain the development of normal and
perturbed embryos (Peter et al., 2012). In the case of the animal caps,
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the absence of Hox11/13b in animal caps had no effect on speciﬁca-
tion of normal animal caps, but that absence prevented the animal
caps from reprogramming to replace endomesodermal fates. Repro-
gramming, as observed here, starts from one attractor (speciﬁcation
state) and transitions into another attractor. In the reprogramming
seen in the present experiments, it appears to pass through an
intermediate phase that can settle into different attractors depending
on the perturbation to the system. What was somewhat surprising to
us was that the capacity for reprogramming was only achieved after
speciﬁcation had progressed both in the animal caps, and in the
NSM, before each was able to respond to missing tissue and
transition to a new state.
Manipulating signaling environment as a possible way of achieving
reprogramming
iPSC induction generally requires forced expression of tran-
scription factors (Yamanaka and Blau, 2010) and in general has low
rates of successful reprogramming (Hochedlinger and Plath, 2009).
In the sea urchin embryo, by contrast, the reprogramming
observed here was highly robust and efﬁcient, required no
introduction of external molecules into the cells and achieved a
high success rate of cell fate conversion. In both the micromere(-)
replacement, and the animal cap reprogramming, signaling had to
be involved. The NSM transfating occurred only in the absence of
PMCs suggesting that the NSM somehow sensed the absence of
the PMCs. The animal caps reprogrammed only after extended
contact with the vegetal half embryos, and the Hox11/13b knock-
down in the vegetal halves suggested that those halves not only
had to undergo speciﬁcation, but also must have supplied the
animal caps with the capacity to reprogram, likely through
signaling. The underlying developmental mechanisms that natu-
rally emerged from evolution make these several reprogramming
cases attractive models for learning principles of cell fate conver-
sion, which may in turn be instructive for iPSC generation.
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